![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | May 2024
The Regulator’s latest blog encouraging innovation in the DB market to offer savers clear benefits and proper protections.
The blog points out that innovation is “fundamental to delivering better outcomes for savers”, but new market propositions should “provide both a clear benefit to savers, and also have the right protections around them”.
The blog goes on to say that the Regulator welcomes the recent higher profile of superfunds and hopes to see an emerging competitive superfund market. However, it urges caution about a possible new offering paying DB pensions to DC members transferring into such a new vehicle, as the regulatory and supervisory frameworks need to be properly developed.
The Regulator plans to develop its regulatory approach to DB alternative arrangements and publish new guidance on these arrangements to help trustees navigate them. It also expects trustees transferring members into a new type of scheme to engage with its market oversight team.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023